Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.43	13.06	11.61	23.18	41.79	67.33
Cash & Short-Term Investments	14.43	13.06	11.61	23.18	41.79	67.33
Cash Growth	44.11%	12.46%	-49.91%	-44.53%	-37.93%	981.18%
Other Receivables	1.7	3.35	3.23	1.61	-	-
Total Trade Receivables	1.7	3.35	3.23	1.61	-	-
Other Current Assets	0.63	1.06	1.44	2.61	3.73	1.53
Total Current Assets	16.76	17.47	16.28	27.4	45.52	68.86
Net Property, Plant & Equipment	2.14	1.03	1.54	2.16	1.54	1.48
Other Intangible Assets	19.23	19.62	17.36	19.56	19.15	-
Goodwill	-	-	-	5.7	5.53	-
Other Long-Term Assets	0.13	0.13	0.17	0.18	0.12	0.02
Total Assets	38.25	38.24	35.35	55.22	71.86	70.37
Accounts Payable	0.61	1.01	0.86	0.77	0.92	0.98
Accrued Expenses	6.49	6.72	4.51	4.51	2.9	2.45
Short-Term Debt	0.04	0.06	0.06	0.06	0.06	-
Current Portion of Leases	0.51	0.55	0.54	0.49	0.22	0.12
Other Current Liabilities	2.62	1.68	1.61	0.91	2.97	-
Total Current Liabilities	10.26	10.01	7.59	6.74	7.06	3.55
Long-Term Debt	1.63	1.67	0.09	0.16	0.22	-
Long-Term Leases	1.52	0.35	0.87	1.44	1.19	1.4
Other Long-Term Liabilities	9.44	10.82	7.74	7.18	8.83	-
Total Long-Term Liabilities	12.59	12.84	8.7	8.78	10.24	1.4
Total Liabilities	22.85	22.86	16.29	15.52	17.3	4.96
Common Stock	0.05	0.03	0	0	0.02	0.01
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-0.29	-
Additional Paid-in Capital	376.02	373.59	355.5	346.54	343.75	336.68
Accumulated Other Comprehensive Income	0.38	0.76	-1.18	0.03	-0.68	-
Retained Earnings	-360.75	-358.71	-334.97	-309.32	-290.97	-271.28
Total Common Shareholders' Equity	15.4	15.38	19.07	36.96	51.83	65.41
Minority Interest	-	-	-	2.73	2.73	-
Shareholders' Equity	15.4	15.38	19.07	39.7	54.56	65.41
Total Liabilities & Equity	38.25	38.24	35.35	55.22	71.86	70.37
Total Debt	3.69	2.63	1.57	2.15	1.68	1.53
Net Cash (Debt)	10.74	10.43	10.04	21.02	40.11	65.8
Net Cash Growth	2.98%	3.81%	-52.22%	-47.58%	-39.05%	1043.52%
Net Cash Per Share	0.49	0.86	7.45	32.63	65.41	134.97
Book Value	15.4	15.38	19.07	36.96	51.83	65.41
Book Value Per Share	0.71	1.27	14.14	57.37	84.54	134.17
Tangible Book Value	-3.83	-4.24	1.71	11.71	27.16	65.41
Tangible Book Value Per Share	-0.18	-0.35	1.27	18.17	44.29	134.17

SEC Filings: 10-K · 10-Q